Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)

From The Alliance for Clinical Trials in Oncology Genitourinary Committee

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Agricultural and Biological Sciences

Food Science